GKB Ophthalmics Limited

Poly Medicure Limited (Polymed) is an Indian medical-device manufacturer that develops and produces disposable healthcare products, including infusion and intravenous therapy devices, blood-management products, dialysis products, and surgical devices. It serves hospitals, clinics, healthcare providers, and medical distributors in India and international markets.

Omega Ophthalmics LLCMedical DevicesUnited States

70% matchPrivate

Omega Ophthalmics LLC develops the Gemini Capsule, an investigational medical implant designed to keep the capsular bag open and provide a stable position for intraocular lenses following cataract removal. The company serves the ophthalmic medical and business sectors by offering solutions to address post-operative capsular contraction.

Eye Bright Medical Technology Co., Ltd., established in 2010 in Beijing, China, specializes in crafting a diverse array of ophthalmic medical solutions. The company's extensive product line is geared towards addressing various ocular conditions and visual impairments, encompassing surgical implants, specialized instruments, and diagnostic equipment, as well as optometric lenses and pharmaceutical eye drops. These innovations are developed to provide treatment for a range of eye diseases, notably cataracts, glaucoma, and refractive errors, among other ophthalmic issues.

STAAR Surgical CompanySTAA · Medical DevicesLake Forest, United States

68% matchPublic

STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness. Furthermore, STAAR Surgical provides preloaded silicone intraocular lenses and associated injector systems, crucial for cataract surgery. The company also sells various injector components and ancillary medical instruments and devices. Its market outreach extends to a diverse array of healthcare providers, such as ophthalmic surgeons, specialized vision and surgical centers, hospitals, governmental healthcare facilities, and distributors. These products are predominantly utilized by ophthalmologists. Sales are conducted directly via its own sales force in key countries like the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore. In other significant markets, including China, Korea, India, France, the Benelux region, Italy, and other international territories, the company employs a hybrid sales model, leveraging both its direct representatives and independent distributors. Founded in 1982, STAAR Surgical Company is headquartered in Lake Forest, California.

ADAPTILENS, LLCTherapeutic DevicesUnited States

67% match

Adaptilens, Inc. is an ophthalmic medical device company headquartered near Boston, Massachusetts, focused on developing advanced accommodating intraocular lenses (IOLs). Founded by ophthalmic device inventors, the company aims to restore natural range of vision for cataract patients through innovative lens technologies. It conducts clinical evaluations and secures venture backing to advance its medical device pipeline.

Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.